NCT04951232View on ClinicalTrials.gov

Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke

NACompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 4, 2016

Primary Completion Date

January 6, 2017

Study Completion Date

January 6, 2017

Conditions
Stroke, Ischemic
Interventions
DRUG

Cinepazide Maleate

The experimental group: guipiprazitel maleate injection (klingo): 320mg (4), dissolved in 500ml of normal saline, and injected in a medium vein at a rate of 100ml/h, once a day, and administered for 14 days.

OTHER

Placebo

Placebo: 4 pieces, dissolved in normal saline 500ml, intravenous drip, the speed is 100ml / h, once a day, continuous administration for 14 days

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

lead

Peking University Third Hospital

OTHER

NCT04951232 - Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter